These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 4020626

  • 21. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T, Follath F, Vozeh S.
    Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
    [Abstract] [Full Text] [Related]

  • 22. Comparative pharmacokinetics of theophylline and ethylenediamine following single and repeated doses of a sustained-release aminophylline preparation to volunteers.
    Cotgreave IA, Caldwell J.
    J Pharm Pharmacol; 1985 Sep; 37(9):618-21. PubMed ID: 2867181
    [Abstract] [Full Text] [Related]

  • 23. Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.
    Weinberger MW, Matthay RA, Ginchansky EJ, Chidsey CA, Petty TL.
    JAMA; 1976 May 10; 235(19):2110-3. PubMed ID: 946537
    [Abstract] [Full Text] [Related]

  • 24. Kinetics of theophylline; variability and effect of arterial pH in chronic obstructive lung disease.
    Resar RK, Walson PD, Fritz WL, Perry DF, Barbee RA.
    Chest; 1979 Jul 10; 76(1):11-6. PubMed ID: 36261
    [Abstract] [Full Text] [Related]

  • 25. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC, Chai H, Miles-Lawrence R, Bell TD, Pinney CT.
    Ann Allergy; 1982 Dec 10; 49(6):315-7. PubMed ID: 7149347
    [Abstract] [Full Text] [Related]

  • 26. [Blood theophylline in patients treated with intravenous aminophylline].
    Curull V, Ruiz I, Ferrer J, Pou L, Morell F.
    Med Clin (Barc); 1986 Mar 08; 86(9):363-5. PubMed ID: 3702528
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW, Zech K, Fischer R.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec 08; 21(12):624-30. PubMed ID: 6668100
    [Abstract] [Full Text] [Related]

  • 28. Theophylline disposition in tetraplegic man.
    Segal JL, Gordon SK, Eltorai IM.
    South Med J; 1987 Jun 08; 80(6):720-4. PubMed ID: 3589764
    [Abstract] [Full Text] [Related]

  • 29. Rapid adjustment of theophylline: a kinetic model.
    Postelnick MJ, Lesher CA, Steiner VI, Nitti JR, Springborn PW, Jaresko GS.
    Drug Intell Clin Pharm; 1984 Jun 08; 18(6):519-22. PubMed ID: 6734437
    [Abstract] [Full Text] [Related]

  • 30. Aminophylline in the emergency department. Maximizing safety and efficacy.
    Kino R, Day RO, Pearce GA, Fulde GW.
    Chest; 1991 Dec 08; 100(6):1572-7. PubMed ID: 1959397
    [Abstract] [Full Text] [Related]

  • 31. A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosage.
    Hurley SF, McNeil JJ.
    Clin Pharmacokinet; 1988 May 08; 14(5):311-20. PubMed ID: 3396259
    [Abstract] [Full Text] [Related]

  • 32. Dose conversion from aminophylline to theophylline in preterm infants.
    Reese J, Prentice G, Yu VY.
    Arch Dis Child Fetal Neonatal Ed; 1994 Jul 08; 71(1):F51-2. PubMed ID: 8092873
    [Abstract] [Full Text] [Related]

  • 33. Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline.
    Vozeh S, Kewitz G, Perruchoud A, Tschan M, Kopp C, Heitz M, Follath F.
    Am Rev Respir Dis; 1982 Feb 08; 125(2):181-4. PubMed ID: 7065521
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics and bronchodilatory effect of proxyphylline and theophylline.
    Rasmussen FV, Waldorff S, Madsen L.
    Eur J Respir Dis; 1984 Jan 08; 65(1):20-7. PubMed ID: 6705854
    [Abstract] [Full Text] [Related]

  • 35. Circadian rhythm in theophylline disposition during a constant-rate intravenous infusion of aminophylline in the dog.
    Rackley RJ, Meyer MC, Straughn AB.
    J Pharm Sci; 1988 Aug 08; 77(8):658-61. PubMed ID: 3210152
    [Abstract] [Full Text] [Related]

  • 36. Use of a pharmacokinetic method for establishing doses of aminophylline to treat acute bronchospasm.
    Pancorbo S, Davies S, Raymond JL.
    Am J Hosp Pharm; 1981 Jun 08; 38(6):851-6. PubMed ID: 7246557
    [Abstract] [Full Text] [Related]

  • 37. Reliability of theophylline clearance in determining maintenance intravenous aminophylline therapy.
    Grambau GR, Johnson CE, Conlon PF, Weg JG.
    J Clin Pharmacol; 1985 Jun 08; 25(5):381-3. PubMed ID: 4031115
    [No Abstract] [Full Text] [Related]

  • 38. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D, Molz KH, Staib AH, Rietbrock N.
    Int J Clin Pharmacol Ther Toxicol; 1981 May 08; 19(5):223-7. PubMed ID: 7251238
    [Abstract] [Full Text] [Related]

  • 39. [Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance].
    Laaban JP, Dupeyron JP, Guyon F, Drieu L, Rochemaure J, Fabiani P.
    Ann Med Interne (Paris); 1986 May 08; 137(5):415-9. PubMed ID: 3813276
    [Abstract] [Full Text] [Related]

  • 40. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB, Guarnone E, Bartoli A, Ciardelli L, Piacentini P.
    Minerva Med; 1985 Mar 31; 76(13):641-5. PubMed ID: 3991030
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.